Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Clostridium difficile polypeptides as vaccine

Clostridium difficile polypeptides as vaccine

US Patent 9932374 · Granted Apr 3, 2018

Estimated economic value: $20,291,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified meningococcal fHbp polypeptides2025
Modified meningococcal fHbp polypeptides2025
Modified meningococcal fHbp polypeptides2025
Vaccines for Neisseria gonorrhoeae2024
Immunogenic compositions comprising OMVs, an acellular pertussis antigen, a teta2024
Vaccines for Neisseria gonorrhoeae2024
Modified meningococcal fHbp polypeptides2024
Modified meningococcal fHbp polypeptides2024
Modified meningococcal FHBP polypeptides2023
Modified meningococcal FHBP polypeptides2021
Modified meningococcal FHBP polypeptides2021
Adjuvanted combinations of meningococcal factor H binding proteins2020